MedTrace Logo

Pangenomic Study During Alcoholic Cirrhosis

NCT01065233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1325

Last updated 2021-09-17

No results posted yet for this study

Summary

Hepatocellular carcinoma (HCC) is a frequent complication of cirrhosis. Occurrence of HCC could be linked with multiple functional region of genome.

The determining of a genomic mapping of " single nucleotide polymorphisms " (SNPs) permit to perform some genetic link studies with pathologies without clear hereditary disposition.

In this study, the investigators will identify predictives genetic polymorphism of HCC.

Conditions

  • Alcoholic Cirrhosis

Interventions

GENETIC

DNA extraction

DNA extraction of blood sample for DNAship analysis

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-23
Primary Completion
2011-12-27
Completion
2013-07-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01065233 on ClinicalTrials.gov